All AAMD members are welcome to attend and learn about the activities and accomplishments of the AAMD over the past year.

Lori Kasuske, President
AAMD

Ryan Moroose, Treasurer
AAMD

Kristi Smith, Regional Director
AAMD

Rachel Hackett, Secretary
AAMD

The MedDos Infinity Task group was formed by the American Association of Medical Dosimetrists (AAMD) to systematically address the development of the medical dosimetry profession in the future. Comprised of a cross-section of the dosimetry profession as well as subject-matter experts within the Radiation Oncology industry, the Task Group has worked since July 2019 to formulate a plan for the continued evolution of the medical dosimetry profession.  The Task Group has focused its’ evaluation efforts on four functional areas: the continued expertise of medical dosimetrists; the role of technology in the profession’s evolution; strategies for sustaining and growing the practice of dosimetry; and efforts to advocate for the profession’s continued advancement.  This presentation will share the results of the MedDos Infinity Task group’s research, findings from the various surveys that have been administered, and recommendations for consideration by the AAMD and its membership for the current and future states of the medical dosimetry profession.

Learner Outcomes:

1. Appreciate that the expertise of the medical dosimetrist is constantly evolving, with potential pathways for growth and development.
2. Realize the importance of the medical dosimetrist's continued involvement in patient care, both through clinical and remote engagements.
3. Recognize how technology is changing and what this may mean for the medical dosimetrist's role as aspects such as artificial intelligence and automation are introduced to the clinical environment.
4. Understand efforts that are underway to grow and sustain the profession, including areas where individuals can support the greater good of the profession.

CE Credits = 1.0

Brian Napolitano, MHL, CMD, Senior Manager, Dosimetry and Physics Administration
Massachusetts General Hospital

Teri Bedard, BA, RT(R)(T), CPC, Executive Director, Client & Corporate Resources
Revenue Cycle Coding Strategies

Dayna Bodensteiner, CMD, RT(R)(T), Director of Product Management, North America
RaySearch Laboratories

Mariel Cornell, BS, CMD, Dosimetry Manager
UC San Diego Department of Radiation Medicine

Catherine Gagne, MBA, CMD, Medical Dosimetrist
Alliance Healthcare Services

This presentation will cover the role of radiation oncology and dosimetry in global health outreach. How are sites assessed? How are programs developed and implemented to help low-resource institutions adopt radiation oncology and diagnostic imaging? How can we better reach underserved communities to provide better access to cancer care?

Learner Outcomes:

1. Assessment methods for understanding health care disparities in radiation oncology
2. Plan global health outreach programs for radiation oncology capacity-building in low and middle-income countries
3. Explain key drivers of health disparities in high, middle and low-income countries

CE Credits = 1.0

Daniel Mollura, MD, President and CEO
RAD-AID International

Jeffrey Antone, Chief Medical Dosimetrist
Northwell Health System

Cancer is one of the most common causes of chronic disease and death in middle-aged to older dogs and cats. Approximately 1 in 4 dogs will, at some point in their lives, develop neoplasia.  Veterinary oncology is a specialized field of veterinary medicine that gives pet owners the opportunity to provide expert cancer treatment to their companion animals after a diagnosis of cancer.  Like in people, radiotherapy plays an important role in veterinary cancer regimes.  This session will provide an overview of the what, when, how, and whys of veterinary radiotherapy and will highlight differences between veterinary and physician-based radiation oncology.  We’ll discuss patient and pet-owner considerations in treatment decision-making, common tumor types, the radiation oncology team, the role of the veterinary radiation oncologist in dosimetry, and the goals of treatment. Veterinary radiation oncology has witnessed an explosion of technology in recent years, dramatically improving the quality of radiotherapy. We’ll discuss this shift towards image-guided IMRT and the emerging role of stereotactic radiation.  

Learner Outcomes:

1. Recognize the role of radiation oncology in veterinary medicine
2. Appreciate the advancement in technology and treatment approaches in companion animal radiotherapy
3. Highlight differences between physician-based and veterinary radiotherapy

CE Credits = 1.0

Michelle Turek, DVM, Dipl.ACVIM (Oncology), Dipl.ACVR (Radiation Oncology), Clinical Associate Professor of Veterinary Radiation Oncology
University of WI-Madison School of Veterinary Medicine

Lori Kasuske, President
AAMD